Position in NVS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$637,536
+$75,569 QoQ
Shares Held
4,068
+10.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#787
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $69,954,680 across 17 Drug Manufacturers - General names. NVS ranks #12 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,352 | $24,410,801 | |
| 2 | ABBV |
AbbVie Inc.
|
52,930 | $13,319,305 | |
| 3 | JNJ |
Johnson & Johnson
|
38,760 | $9,843,877 | |
| 4 | PFE |
Pfizer Inc
|
228,411 | $5,500,136 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,895 | $3,970,007 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,120 | $3,291,254 | |
| 7 | AMGN |
Amgen Inc
|
8,216 | $2,975,177 | |
| 8 | NVO |
Novo Nordisk A S
|
30,253 | $1,450,328 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $637,536 | 4,068 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $561,967 | 3,679 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $409,611 | 2,971 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $304,057 | 2,371 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $236,211 | 1,952 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $238,232 | 2,137 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $168,346 | 1,730 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $158,267 | 1,376 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $261,891 | 2,460 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $143,547 | 1,484 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $254,343 | 2,519 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $405,912 | 3,985 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $213,828 | 2,119 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $285,752 | 3,106 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $425 | 6,792 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $587,785 | 7,733 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $660,179 | 7,810 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $272,902 | 3,110 | Shares | Sole | 2022-08-08 | |
| 2021-12-31 | $226,109 | 2,585 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $236,507 | 2,892 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $142,881 | 1,566 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $117,107 | 1,370 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $124,930 | 1,323 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $137,657 | 1,583 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $162,190 | 1,857 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $184,770 | 2,241 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||